Elicio Therapeutics (ELTX)
14.30
0.00 (0.00%)
Upcoming Events
Latest Headlines
B.Riley Starts Elicio Therapeutics (ELTX) at Buy
June 10, 2026 8:28 AM - StreetInsider
Elicio Therapeutics publishes research on AMP-DNA adjuvant technology
June 1, 2026 8:04 AM - StreetInsider
Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology
June 1, 2026 8:00 AM - StreetInsider
Elicio Therapeutics (ELTX) Misses Q1 EPS by 65c
May 11, 2026 5:13 PM - StreetInsider
Form 10-Q Elicio Therapeutics, For: Mar 31
May 11, 2026 4:14 PM - SEC Filing
Form 8-K Elicio Therapeutics, For: May 11
May 11, 2026 4:10 PM - SEC Filing
Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 11, 2026 4:05 PM - StreetInsider
Elicio Therapeutics to Present at the Bank of America Healthcare Conference
April 30, 2026 8:00 AM - Globe NewsWire
Form 10-K/A Elicio Therapeutics, For: Dec 31
April 29, 2026 4:09 PM - SEC Filing
Elicio Therapeutics Reports Inducement Grants
April 16, 2026 11:42 AM - Globe NewsWire
Elicio Therapeutics Reports Inducement Grants
April 16, 2026 8:00 AM - StreetInsider
Ladenburg Thalmann Starts Elicio Therapeutics (ELTX) at Buy
April 15, 2026 6:36 AM - StreetInsider
Jones Trading Assumes Elicio Therapeutics (ELTX) at Buy
April 6, 2026 4:16 PM - StreetInsider
Advancements in Novel Immunotherapeutics in The Oncology Battle
March 24, 2026 10:32 AM - StreetInsider
Elicio Therapeutics Reports Inducement Grants
March 17, 2026 8:00 AM - StreetInsider
Form EFFECT Elicio Therapeutics,
March 17, 2026 6:10 AM - SEC Filing
Form 8-K Elicio Therapeutics, For: Mar 16
March 16, 2026 9:20 AM - SEC Filing
Form 424B5 Elicio Therapeutics,
March 16, 2026 9:19 AM - SEC Filing
Elicio Therapeutics (ELTX) PT Raised to $17 at H.C. Wainwright
March 13, 2026 6:43 AM - StreetInsider
Full Article List
